Revisiting an old antibiotic: bacitracin neutralizes binary bacterial toxins and protects cells from intoxication.
Animals
Anti-Bacterial Agents
/ pharmacology
Antigens, Bacterial
/ metabolism
Bacillus anthracis
/ drug effects
Bacitracin
/ pharmacology
Bacterial Toxins
/ metabolism
Biological Transport
/ drug effects
Caco-2 Cells
Cell Line, Tumor
Cell Membrane
/ drug effects
Chlorocebus aethiops
Clostridioides difficile
/ drug effects
Cytosol
/ drug effects
Endocytosis
/ drug effects
Endosomes
/ drug effects
Exotoxins
/ metabolism
HeLa Cells
Humans
Lipid Bilayers
/ metabolism
Protective Agents
/ pharmacology
Protein Transport
/ drug effects
Vero Cells
anthrax toxin
bacterial binary AB-toxins
toxin inhibitor
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
pubmed:
31
1
2019
medline:
12
5
2020
entrez:
31
1
2019
Statut:
ppublish
Résumé
The antibiotic bacitracin (Bac) inhibits cell wall synthesis of gram-positive bacteria. Here, we discovered a totally different activity of Bac: the neutralization of bacterial exotoxins. Bac prevented intoxication of mammalian cells with the binary enterotoxins Clostridium botulinum C2, C. perfringens ι, C. difficile transferase (CDT), and Bacillus anthracis lethal toxin. The transport (B) subunits of these toxins deliver their respective enzyme (A) subunits into cells. Following endocytosis, the B subunits form pores in membranes of endosomes, which mediate translocation of the A subunits into the cytosol. Bac inhibited formation of such B pores in lipid bilayers in vitro and in living cells, thereby preventing translocation of the A subunit into the cytosol. Bac preserved the epithelial integrity of toxin-treated CaCo-2 monolayers, a model for the human gut epithelium. In conclusion, Bac should be discussed as a therapeutic option against infections with medically relevant toxin-producing bacteria, including C. difficile and B. anthracis, because it inhibits bacterial growth and neutralizes the secreted toxins.-Schnell, L., Felix, I., Müller, B., Sadi, M., von Bank, F., Papatheodorou, P., Popoff, M. R., Aktories, K., Waltenberger, E., Benz, R., Weichbrodt, C., Fauler, M., Frick, M., Barth, H. Revisiting an old antibiotic: bacitracin neutralizes binary bacterial toxins and protects cells from intoxication.
Identifiants
pubmed: 30699302
doi: 10.1096/fj.201802453R
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antigens, Bacterial
0
Bacterial Toxins
0
Exotoxins
0
Lipid Bilayers
0
Protective Agents
0
anthrax toxin
0
Bacitracin
1405-87-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM